acetaminophen has been researched along with Hepatolenticular Degeneration in 6 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.
Excerpt | Relevance | Reference |
---|---|---|
" In Europe and North America a large proportion of cases are due to acetaminophen and to idiosyncratic drug reactions, whereas reports from emerging countries in Asia and Africa feature viral illnesses, particularly hepatitis B and E." | 4.84 | Etiologies of acute liver failure. ( Lee, WM, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di Giorgio, A | 1 |
Nicastro, E | 1 |
Dalla Rosa, D | 1 |
Nebbia, G | 1 |
Sonzogni, A | 1 |
D'Antiga, L | 1 |
Rajaram, P | 1 |
Subramanian, R | 1 |
Olson, KR | 1 |
Davarpanah, AH | 1 |
Schaefer, EA | 1 |
Elias, N | 1 |
Misdraji, J | 1 |
Gandhi, H | 1 |
Davies, N | 1 |
Lee, WM | 1 |
Ryder, SD | 1 |
Beckingham, IJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure/Severe Acute Liver Injury[NCT01548690] | Phase 2 | 47 participants (Actual) | Interventional | 2012-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
To evaluate the effect of OCR-002 on ammonia levels in patients with acute liver failure/severe acute liver injury (NCT01548690)
Timeframe: Baseline and 72 Hours
Intervention | Percent Change (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 41.2 |
Maximum Dose Level 6.65 g/24h | 16.6 |
Maximum Dose Level 10 g/24h | 41.8 |
Maximum Dose Level 20g/24h | 38.4 |
To evaluate the steady state pharmacokinetic and pharmacodynamic profile of OCR-002 in patients with impaired and intact renal function using urinary phenylacetylglutamine (PAGN) as a surrogate marker (NCT01548690)
Timeframe: 24 Hours after last infusion
Intervention | micrograms per millileter (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 65.6 |
Maximum Dose Level 6.65 g/24h | 32.2 |
Maximum Dose Level 10 g/24h | 33.4 |
Maximum Dose Level 20g/24h | 104.9 |
The orientation log focuses on orientation to place, time, and circumstance. There are 10 items on the orientation log, which are scored 0-3. A spontaneous correct response is awarded 3 points. A spontaneous response that is lacking or incorrect, but a correct response is provided following a logical cue is awarded 2 points. A score of 1 is given if spontaneous and cued responses are lacking or incorrect, but a correct response is provided in a recognition format. A score of 0 is given if the spontaneous, cued, or recognition format does not generate a correct answer. Scores from the 10 items are summed and the final score ranges from 0 to 30. (NCT01548690)
Timeframe: 30 Days
Intervention | units on a scale (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 23.8 |
Maximum Dose Level 6.65 g/24h | 24.0 |
Maximum Dose Level 10 g/24h | 24.0 |
Maximum Dose Level 20g/24h | 24.0 |
The West Haven Criteria (WHC) for Hepatic Encephalopathy measures the severity of encephalopathy and patient's level of consciousness. The scale ranges from 0 to 4; a minimum score of 0 represents a better outcome, and a maximum total score of 4 represents a worse outcome. A score of 0 corresponds to normal consciousness and behavior and normal neurological examination. A score of 1 corresponds to mild lack of awareness, shortened attention span, and impaired addition or subtraction; mild asterixis or tremor. A score of 2 corresponds to lethargy, disorientated or inappropriate behavior, obvious asterixis; slurred speech. A score of 3 corresponds to somnolent but arousable, gross disorientation or bizarre behavior, muscle rigidity and clonus; hyperreflexia. A score of 4 corresponds to coma and decerebrate posturing. (NCT01548690)
Timeframe: 120 hours from start of infusion
Intervention | units on a scale (Mean) |
---|---|
Maximum Dose Level 3.33 g/24h | 2.4 |
Maximum Dose Level 6.65 g/24h | 3.2 |
Maximum Dose Level 10 g/24h | 1.6 |
Maximum Dose Level 20g/24h | 1.8 |
To evaluate the safety and tolerability of OCR-002 in patients with acute liver failure/severe acute liver injury (NCT01548690)
Timeframe: 30 Days
Intervention | Participants (Count of Participants) |
---|---|
Maximum Dose Level 3.33 g/24h | 0 |
Maximum Dose Level 6.65 g/24h | 0 |
Maximum Dose Level 10 g/24h | 0 |
Maximum Dose Level 20g/24h | 0 |
3 reviews available for acetaminophen and Hepatolenticular Degeneration
Article | Year |
---|---|
Acute Liver Failure.
Topics: Acetaminophen; Chemical and Drug Induced Liver Injury; Critical Care; Drug Overdose; Hepatitis, Auto | 2018 |
Etiologies of acute liver failure.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Budd-Chiari Syndrome; Drug-Related Side Effects and Adverse | 2008 |
ABC of diseases of liver, pancreas, and biliary system. Other causes of parenchymal liver disease.
Topics: Acetaminophen; Cholangitis, Sclerosing; Cholestasis; Drug Hypersensitivity; Hemochromatosis; Hepatit | 2001 |
3 other studies available for acetaminophen and Hepatolenticular Degeneration
Article | Year |
---|---|
Transplant-free Survival in Chronic Liver Disease Presenting as Acute Liver Failure in Childhood.
Topics: Acetaminophen; Child; Child, Preschool; End Stage Liver Disease; Female; Graft Survival; Hepatic Enc | 2019 |
Case 2-2017. An 18-Year-Old Woman with Acute Liver Failure.
Topics: Abdomen; Acetaminophen; Adolescent; Diagnosis, Differential; Female; Hepatolenticular Degeneration; | 2017 |
Liver transplant and obstetrics.
Topics: Acetaminophen; Adult; Congenital Abnormalities; Drug Overdose; Female; Hepatolenticular Degeneration | 2004 |